DEERFIELD, Ill., Nov. 25, 2014 – Walgreens (NYSE: WAG) (Nasdaq: WAG) today said that on Nov. 24 it filed and began mailing to its shareholders the definitive proxy statement/final prospectus relating to a special meeting of shareholders, which will take place Dec. 29 in New York City. This follows the announcement made on Aug. 6 […]
CHESHIRE, Conn. November 25, 2014 –(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Soliris® (eculizumab) has been granted orphan drug designation (ODD) by Japan’s Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with neuromyelitis optica (NMO), a life-threatening, ultra-rare neurologic disorder. In patients with NMO, chronic, uncontrolled complement activation results in severe […]
THOUSAND OAKS, Calif., Nov. 24, 2014 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the termination of all Amgen-sponsored clinical studies of rilotumumab in advanced gastric cancer, including the Phase 3 RILOMET-1 and RILOMET-2 studies. Amgen’s decision is based on a planned safety review by the RILOMET-1 independent data monitoring committee that found an increase in the […]
Member Physicians, Rite Aid Pharmacists and Special Care Coaches to Provide Personalized, Community-Based Health Management to Chronic and Poly-Chronic Patients CAMP HILL, Pa. (November 20, 2014) – Rite Aid Corporation (NYSE:RAD) has announced Quality Independent Physicians, based in Louisville, as the latest healthcare provider to join its Rite Aid Health Alliance initiative. Through Rite Aid […]
November 20, 2014 — Research outlining the impact physical wellness has on financial well-being was unveiled last week at the Filene Research Institute’s “big. bright. minds.” 2014 conference. Working with hubbub health® and TwinStar Credit Union, a group of credit union executives in Filene’s i3 program launched a pilot program that demonstrated the relationship between […]
WOONSOCKET, R.I., Nov. 20, 2014 /PRNewswire/ — CVS Health (NYSE: CVS) today announced that the company and its foundation has committed to invest more than $1 million in grants to support tobacco cessation and prevention programs. The grants will be distributed to leading health care and community partners working to promote tobacco-free communities, programs that […]
GE Healthcare to offer Caradigm’s Identity and Access Management suite with Omnyx digital pathology solutions to streamline pathology workflows. PITTSBURGH, PA – November 19, 2014 – GE Healthcare, a leader in technology innovation, today announced it will resell Caradigm’s Single Sign-On and Context Management solutions in the United States, Canada, and specific EU countries to […]
Phase 3 Clinical Trial Enrollment Scheduled to Start by the End of 2014 WHITEHOUSE STATION, N.J., November 3, 2014 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of results from a Phase 2b clinical trial evaluating the safety and efficacy of once-daily oral doravirine, an investigational next-generation […]
WOONSOCKET, R.I., Nov. 19, 2014 /PRNewswire/ — CVS Health announced today that it received a score of 100 percent on the 2015 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to LGBT workplace equality, administered by the Human Rights Campaign Foundation. CVS Health’s satisfaction of all of […]
Additional Data Analysis Showed Every Two Week and Monthly Dosing Regimens of Evolocumab Were Clinically Equivalent Amgen to Webcast Investor Call at AHA Scientific Sessions 2014 THOUSAND OAKS, Calif., Nov. 18, 2014 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced new data from three separate analyses of Phase 2 and 3 studies evaluating evolocumab, a novel investigational […]
